13F filer · CIK 2100119 ↗
Vanguard Capital Management
You are looking at Q3 2022. See the latest, Q2 2026 →
Reported value
$3.40T
−4.4% on the quarter before
Positions
4,604
89 new · 106 sold out
Top 10
20.5%
of the value
Est. gain
−$181.71B
on stocks held all quarter
Est. return
−5.2%
on those stocks since Q2 2022
Positions as of Sep 30, 2022, from Vanguard Capital Management's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 30% of the reported value, each sized by its share, colored by what the fund did with it since Q2 2022. Striped tiles are options.
Largest buys
Since Q2 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Tesla~$2.20BAdded · 1.3% → 1.7%+8,305,933 shares
- Jacobs Solutions Inc~$1.54BNew · 0.0% → 0.0%+14,167,582 shares
- Microsoft~$1.43BAdded · 4.5% → 4.3%+6,129,708 shares
- Amazon~$1.41BAdded · 2.1% → 2.3%+12,456,995 shares
- Healthcare Rlty Tr~$1.14BNew · 0.0% → 0.0%+54,590,406 shares
- Annaly Capital Management In~$704.7MNew · 0.0% → 0.0%+41,065,547 shares
- Yum China Hldgs Inc~$698.5MAdded · 0.0% → 0.0%+14,757,971 shares
- Aspen Technology Inc~$662.6MNew · 0.0% → 0.0%+2,781,490 shares
- Costar Group Inc~$541.9MAdded · 0.1% → 0.1%+7,780,240 shares
- Johnson & Johnson~$460.0MAdded · 1.2% → 1.2%+2,815,655 shares
Largest sells
Since Q2 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Jacobs Solutions~$1.80BSold out · 0.1% → 0.0%−14,155,470 shares
- American Campus Cmntys Inc~$1.29BSold out · 0.0% → 0.0%−20,080,308 shares
- Occidental Pete Corp~$1.15BCut · 0.1% → 0.1%−18,761,473 shares
- Healthcare Tr Amer Inc~$888.2MSold out · 0.0% → 0.0%−31,825,432 shares
- Annaly Capital Management In~$850.0MSold out · 0.0% → 0.0%−143,821,556 shares
- Apple~$682.7MCut · 4.9% → 5.2%−4,940,153 shares
- Chevron Corp New~$658.1MCut · 0.7% → 0.7%−4,580,670 shares
- Synopsys~$635.4MCut · 0.1% → 0.1%−2,079,699 shares
- Coherent Inc~$625.2MSold out · 0.0% → 0.0%−2,348,580 shares
- Palo Alto Networks~$624.8MCut · 0.1% → 0.1%−3,814,603 shares
Holdings
As of Sep 30, 2022. Changes are in shares against Jun 30, 2022, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AppleCOM · shares −0.4% · price +1.1% | 5.2% | $175.84B | +$1.88B | ||||||||
| MicrosoftCOM · shares +1.0% · price −9.3% | 4.3% | $147.71B | −$15.03B | ||||||||
| AmazonCOM · shares +1.8% · price +6.4% | 2.3% | $79.28B | +$4.68B | ||||||||
| TeslaCOM · shares +4.1% · price +18.2% | 1.7% | $56.50B | +$8.35B | ||||||||
| AlphabetCAP STK CL A · shares +1.0% · price −12.2% | 1.3% | $45.63B | −$6.29B | ||||||||
| Unitedhealth Group IncCOM · shares +1.0% · price −1.7% | 1.2% | $41.90B | −$705.4M | ||||||||
| AlphabetCAP STK CL C · shares −0.7% · price −12.1% | 1.2% | $40.59B | −$5.58B | ||||||||
| Johnson & JohnsonCOM · shares +1.2% · price −8.0% | 1.2% | $40.08B | −$3.43B | ||||||||
| Berkshire Hathaway Inc DelCL B NEW · shares +1.1% · price −2.2% | 1.1% | $36.59B | −$812.9M | ||||||||
| Exxon Mobil CorpCOM · shares +0.1% · price +2.0% | 0.95% | $32.19B | +$615.1M | ||||||||
| Jpmorgan Chase & CoCOM · shares +1.1% · price −7.2% | 0.84% | $28.48B | −$2.19B | ||||||||
| Procter And Gamble CoCOM · shares +1.0% · price −12.2% | 0.83% | $28.35B | −$3.90B | ||||||||
| Home Depot IncCOM · shares +1.1% · price +0.6% | 0.77% | $26.06B | +$156.0M | ||||||||
| Visa Inc.COM CL A · shares +0.6% · price −9.8% | 0.76% | $25.80B | −$2.78B | ||||||||
| NvidiaCOM · shares +1.2% · price −19.9% | 0.73% | $24.73B | −$6.08B | ||||||||
| MetaCL A · shares +0.5% · price −15.9% | 0.72% | $24.61B | −$4.61B | ||||||||
| Eli LillyCOM · shares +1.4% · price −0.3% | 0.69% | $23.47B | −$63.0M | ||||||||
| Chevron Corp NewCOM · shares −2.8% · price −0.8% | 0.67% | $22.89B | −$176.9M | ||||||||
| MastercardCL A · shares +0.7% · price −9.9% | 0.65% | $21.97B | −$2.39B | ||||||||
| Pfizer IncCOM · shares +1.1% · price −16.5% | 0.64% | $21.60B | −$4.23B | ||||||||
| Pepsico IncCOM · shares +1.3% · price −2.0% | 0.62% | $21.03B | −$432.6M | ||||||||
| Abbvie IncCOM · shares +1.6% · price −12.4% | 0.62% | $20.94B | −$2.91B | ||||||||
| Coca Cola CoCOM · shares +1.1% · price −11.0% | 0.60% | $20.35B | −$2.48B | ||||||||
| Merck & Co IncCOM · shares +1.4% · price −5.5% | 0.57% | $19.30B | −$1.12B | ||||||||
| Costco Whsl Corp NewCOM · shares +1.3% · price −1.5% | 0.54% | $18.43B | −$270.2M | ||||||||
| Total · 4,604 positions | 100% | $3.40T | −$181.71B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q2 2022 to Q3 2022: 4,514 stocks held throughout, down $181.71B (−5.2%).
- Tesla3:1 split+$8.35B+18%
- Amazon+$4.68B+6%
- Netflix+$2.09B+35%
- Apple+$1.88B+1%
- PayPal+$1.54B+23%
- Meta−$4.61B−16%
- Alphabet20:1 split−$5.58B−12%
- Nvidia−$6.08B−20%
- Alphabet20:1 split−$6.29B−12%
- Microsoft−$15.03B−9%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 12 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 13, 2026 | $4.68T+17% | SEC ↗ |
| Q1 2026 | May 15, 2026 (amended) | $4.00T−42% | SEC ↗ |
| Q4 2025 | Jan 29, 2026 | $6.90T+3% | SEC ↗ |
| Q3 2025 | Nov 7, 2025 | $6.68T+8% | SEC ↗ |
| Q2 2025 | Aug 11, 2025 | $6.18T+12% | SEC ↗ |
| Q1 2025 | May 9, 2025 | $5.53T−4% | SEC ↗ |
| Q4 2024 | Feb 11, 2025 | $5.74T+3% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $5.58T+7% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $5.21T+3% | SEC ↗ |
| Q1 2024 | May 10, 2024 | $5.05T+10% | SEC ↗ |
| Q4 2023 | Mar 11, 2024 (amended) | $4.58T+12% | SEC ↗ |
| Q3 2023 | Dec 18, 2023 (amended) | $4.07T−3% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $4.22T+7% | SEC ↗ |
| Q1 2023 | Jul 14, 2023 (amended) | $3.93T+7% | SEC ↗ |
| Q4 2022 | Feb 10, 2023 | $3.67T+8% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $3.40T−4% | SEC ↗ |
| Q2 2022 | Aug 12, 2022 | $3.56T−16% | SEC ↗ |
| Q1 2022 | May 13, 2022 | $4.23T−4% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $4.40T+9% | SEC ↗ |
| Q3 2021 | Nov 12, 2021 | $4.03T+0% | SEC ↗ |
| Q2 2021 | Aug 13, 2021 | $4.02T+9% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $3.70T+7% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $3.45T+14% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $3.02T+7% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $2.82T+20% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $2.35T−20% | SEC ↗ |
| Q4 2019 | Feb 14, 2020 | $2.93T+9% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $2.70T+1% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $2.66T+4% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $2.55T+15% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $2.23T−13% | SEC ↗ |
| Q3 2018 | Dec 13, 2018 (amended) | $2.56T+7% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $2.39T+5% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $2.29T−0% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $2.29T+7% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $2.14T+5% | SEC ↗ |
| Q2 2017 | Aug 24, 2017 (amended) | $2.03T+4% | SEC ↗ |
| Q1 2017 | May 12, 2017 | $1.95T+9% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $1.79T+5% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $1.70T+6% | SEC ↗ |
| Q2 2016 | Aug 10, 2016 | $1.61T+4% | SEC ↗ |
| Q1 2016 | May 13, 2016 | $1.54T | SEC ↗ |